DK1366033T3 - Kemiske forbindelser - Google Patents

Kemiske forbindelser

Info

Publication number
DK1366033T3
DK1366033T3 DK01994312T DK01994312T DK1366033T3 DK 1366033 T3 DK1366033 T3 DK 1366033T3 DK 01994312 T DK01994312 T DK 01994312T DK 01994312 T DK01994312 T DK 01994312T DK 1366033 T3 DK1366033 T3 DK 1366033T3
Authority
DK
Denmark
Prior art keywords
chemical compounds
formula
compounds
present
beta
Prior art date
Application number
DK01994312T
Other languages
Danish (da)
English (en)
Inventor
David Edward Uehling
David N Deaton
Barry George Shearer
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Application granted granted Critical
Publication of DK1366033T3 publication Critical patent/DK1366033T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • External Artificial Organs (AREA)
  • Mechanical Coupling Of Light Guides (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK01994312T 2001-01-31 2001-12-17 Kemiske forbindelser DK1366033T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0102408.2A GB0102408D0 (en) 2001-01-31 2001-01-31 Chemical compounds
PCT/US2001/049299 WO2002060885A1 (en) 2001-01-31 2001-12-17 Chemical compounds

Publications (1)

Publication Number Publication Date
DK1366033T3 true DK1366033T3 (da) 2005-08-15

Family

ID=9907834

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01994312T DK1366033T3 (da) 2001-01-31 2001-12-17 Kemiske forbindelser

Country Status (23)

Country Link
EP (1) EP1366033B1 (pt)
JP (1) JP2004521895A (pt)
KR (1) KR20030070923A (pt)
CN (1) CN1487928A (pt)
AT (1) ATE294167T1 (pt)
AU (1) AU2002246720B2 (pt)
BR (1) BR0116854A (pt)
CA (1) CA2434853A1 (pt)
CZ (1) CZ20032085A3 (pt)
DE (1) DE60110468T2 (pt)
DK (1) DK1366033T3 (pt)
ES (1) ES2240557T3 (pt)
GB (1) GB0102408D0 (pt)
HK (1) HK1060883A1 (pt)
HU (1) HUP0303026A3 (pt)
IL (2) IL156639A0 (pt)
MX (1) MXPA03006847A (pt)
NO (1) NO20033401L (pt)
NZ (1) NZ526846A (pt)
PL (1) PL363359A1 (pt)
PT (1) PT1366033E (pt)
WO (1) WO2002060885A1 (pt)
ZA (1) ZA200305770B (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0102407D0 (en) 2001-01-31 2001-03-14 Glaxo Group Ltd Process
US7709677B2 (en) 2001-01-31 2010-05-04 Glaxosmithkline Llc Process of preparing arylethanoldiamines
EP1424079A1 (en) * 2002-11-27 2004-06-02 Boehringer Ingelheim International GmbH Combination of a beta-3-receptor agonist and of a reuptake inhibitor of serotonin and/or norepinephrine

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9207964D0 (en) * 1992-04-10 1992-05-27 Ici Plc Chemical compounds
WO1995033724A1 (en) * 1994-06-09 1995-12-14 Glaxo Group Limited Phenethanolamine derivatives and their use as atypical beta-adrenoceptor agonists
GB9525177D0 (en) * 1995-12-08 1996-02-07 Glaxo Group Ltd Chemical compounds
GB9812709D0 (en) * 1998-06-13 1998-08-12 Glaxo Group Ltd Chemical compounds

Also Published As

Publication number Publication date
CZ20032085A3 (cs) 2003-12-17
IL156639A (en) 2006-12-31
BR0116854A (pt) 2004-02-25
PL363359A1 (en) 2004-11-15
GB0102408D0 (en) 2001-03-14
HUP0303026A3 (en) 2007-06-28
PT1366033E (pt) 2005-08-31
NO20033401L (no) 2003-09-30
EP1366033B1 (en) 2005-04-27
MXPA03006847A (es) 2003-11-13
ATE294167T1 (de) 2005-05-15
DE60110468T2 (de) 2006-02-23
WO2002060885A1 (en) 2002-08-08
CA2434853A1 (en) 2002-08-08
KR20030070923A (ko) 2003-09-02
AU2002246720B2 (en) 2004-07-22
ZA200305770B (en) 2004-10-25
DE60110468D1 (de) 2005-06-02
NO20033401D0 (no) 2003-07-30
EP1366033A1 (en) 2003-12-03
IL156639A0 (en) 2004-01-04
ES2240557T3 (es) 2005-10-16
JP2004521895A (ja) 2004-07-22
NZ526846A (en) 2004-10-29
CN1487928A (zh) 2004-04-07
HUP0303026A2 (hu) 2003-12-29
HK1060883A1 (en) 2004-08-27

Similar Documents

Publication Publication Date Title
EA200601552A1 (ru) Замещенные конденсированные гетероциклические с-гликозиды
EA200601554A1 (ru) Замещенные индол-о-глюкозиды
EA200601553A1 (ru) Замещенные бензимидазол-, бензтриазол- и бензимидазолон-о-глюкозиды
EA200501771A1 (ru) Лиганды каннабиноидных рецепторов и их применения
ATE449097T1 (de) Pyridoä2,3-düpyrimidin-2,4-diamin-verbindungen als ptpib-hemmer
UA86042C2 (en) Substituted indazole-o-glucosides
BG108225A (en) Thiohydantoins and use thereof for treating diabetes
NO20055741D0 (no) Nye kjemiske forbindelser
DK1206474T3 (da) Sulfonylphenylpyrazolforbindelser anvendelige som cox-2-inhibitorer
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
DK1560812T3 (da) Aminocyclohexyletherforbindelser og anvendelser deraf
ATE312096T1 (de) Neue verbindungen
NO20043016L (no) 6-aminomorfinan-derivater, fremgangsmate for fremstilling og anvendelse derav
PT1267869E (pt) Antogonistas de receptor de glutamato metabotropico para o tratamento de tolerancia e de dependencia
ATE319439T1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
MY141528A (en) Anilinopyrazole derivatives useful for the treatment of diabetes
NL1021504A1 (nl) Waterstofbehandelingsproces.
SE0302304D0 (sv) Novel compounds
DE50205466D1 (de) Substituierte 2,5-diamidoindole als ece-inhibitoren zur behandlung von kardiovaskulären erkrankungen
DK1438034T3 (da) Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens
DK1366033T3 (da) Kemiske forbindelser
NO20053562L (no) Nye aminobenzofenonforbindelser
ATE277924T1 (de) Aryl-8-azabicyclo(3.2.1)octanes für die behandlung von depression
DE60326348D1 (de) Makrozyclen zur behandlung von krebserkrankungen
SE0202608D0 (sv) New sequences